GGrantIndex
Sort

15,273 grants matching antimicrobial resistance

Central role of Caspase-8 in control of host tolerance and resistance mechanisms in pulmonary macrophage populations during severe respiratory infections

$757,662
Amanda M Jamieson · Brown University · R01 · FY2024 · HL

Rapid and Expandable Nucleic Acid Platform to Detect Bloodstream Infections

$757,554
David S Perlin · Univ Of Med/Dent Of Nj-Nj Medical School · U01 · FY2008 · AI

Microbial genomics of hospital-associated pathogens

$757,418
Julia Angela Segre · National Human Genome Research Institute · ZIA · FY2025 · HG

Novel Combination Therapies to Combat Hypermutable Carbapenem-Resistant P. aeruginosa

$757,308
Brian Tsuji · State University Of New York At Buffalo · R01 · FY2025 · AI

De Novo Synthesis, and Functional and Structural Characterization of Novel Aminoglycoside Analogues to Bypass Resistance Mechanisms and Optimize Selectivity

$757,156
James E Kirby · Beth Israel Deaconess Medical Center · R01 · FY2023 · AI

Development of novel anti-Neisseria gonorrhoeae therapeutic agents

$757,023
Daniel Patrick Flaherty · Purdue University · R01 · FY2024 · AI

Population Genomic Analysis of Gut Microbial Colonization in Premature Infants

$756,839
Jillian Banfield · University Of California Berkeley · R01 · FY2024 · AI

Phase II Clinical Trial to Evaluate a Vaccine Candidate for Gonorrhea

$756,120
National Institute Of Allergy And Infectious Diseases · Y01 · FY2021 · AI

Novel tools for measuring typhoid vaccine impact

$756,045
Jason Randolph Andrews · Stanford University · R01 · FY2024 · AI

Exploiting antibody catalysis for treating Cryptococcosis

$755,763
Arturo Casadevall · Johns Hopkins University · R01 · FY2023 · AI

The clinical and molecular epidemiology of colistin-resistant carbapenem-resistant Enterobacteriaceae (CRE) in long-term acute care hospitals (LTACHs)

$755,729
Ebbing Lautenbach · University Of Pennsylvania · R01 · FY2022 · AI

Developing therapeutics to treat chronic infections

$755,183
Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2018 · AI

Mechanisms of multi-species bacterial interactions

$754,712
Anupama Khare · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Development of Microbiome-Sparing Antibacterials for Clostridioides difficile Infection

$754,446
Kirk Edward Hevener · University Of Tennessee Health Sci Ctr · R01 · FY2025 · AI

Development of novel anti-Neisseria gonorrhoeae therapeutic agents

$753,923
Daniel Patrick Flaherty · Purdue University · R01 · FY2025 · AI

Neuronal Latency and Toxoplasma

$753,911
Christopher A Hunter · University Of Pennsylvania · R01 · FY2022 · AI

The impact of bacteriophage therapy on wound infection dynamics

$753,522
Daniel J Wozniak · Ohio State University · R01 · FY2024 · AI

Integrated Antimicrobial Drug Discovery Scheme for Multidrug Resistant Bacteria

$753,442
Zoltan N. Oltvai · University Of Pittsburgh At Pittsburgh · U01 · FY2006 · AI

A comprehensive investigation of Pseudomonas quorum sensing regulatory relationships and the consequences on quorum sensing inhibitors in complex communities

$753,257
Laurence G Rahme · Massachusetts General Hospital · R01 · FY2023 · AI

Rapid, Breath Volatile Metabolite-Based Diagnosis, Species Identification, and Antibiotic Resistance Profiling in Bacterial Pneumonia

$753,224
Sophia Koo · Brigham And Women'S Hospital · R01 · FY2025 · AI

Molecular Mechanisms of Inflammation, Steatosis and Hepatic Insulin Resistance

$753,204
Jerrold M Olefsky · University Of California, San Diego · R24 · FY2010 · DK

Central role of Caspase-8 in control of host tolerance and resistance mechanisms in pulmonary macrophage populations during severe respiratory infections

$753,052
Amanda M Jamieson · Brown University · R01 · FY2025 · HL

Determining How a Dynamic Microbiome Contributes to Cystic Fibrosis Lung Disease

$753,021
Robert Andrew Quinn · Michigan State University · R01 · FY2020 · AI

Multiscale modeling of the battle over iron in invasive lung infection

$752,823
Reinhard Laubenbacher · University Of Florida · R01 · FY2020 · AI

The impact of bacteriophage therapy on wound infection dynamics

$752,735
Daniel J Wozniak · Ohio State University · R01 · FY2023 · AI